AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Letrigo 2.5mg Tablet

Prescription Icon
Prescription Required

Marketer

Fenestra Pharmaceuticals

Salt Composition

Letrozole (2.5mg)

Overview Letrigo 2.5mg Tablet

Post-menopausal women with breast cancer may find relief with Letrigo 2.5mg Tablets. This medication can be administered independently or concurrently with other therapies like surgery or radiotherapy. In advanced breast cancer, it aids in preventing metastasis. Letrigo 2.5mg Tablets can be ingested with or without food, always adhering to the physician's prescribed dosage and duration for optimal results. Dosage frequency varies depending on the treatment goal, determined by your doctor to manage symptoms effectively. Continuous use, as directed, is crucial. Commonly reported side effects include increased perspiration, weariness, hot flashes, and elevated cholesterol (hypercholesterolemia). Report any concerning or persistent side effects immediately. Your physician can offer strategies for mitigation. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, or a history of osteoporosis. Comprehensive disclosure of all other medications is essential, as interactions can impact Letrigo's efficacy. Disclose pregnancy or breastfeeding status to your doctor. Pre- and ongoing treatment blood tests to monitor vitamin D levels and bone density may be conducted.

Uses of Letrigo 2.5mg Tablet

Managing Breast Cancer

Major Benefits of Letrigo 2.5mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the 2.5mg Letrigo tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, although consistent timing is recommended.

Common Side effects of Letrigo 2.5mg Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Letrigo 2.5mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the 2.5mg Letrigo tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, though consistent timing is recommended.

How Letrigo 2.5mg Tablet works:

Letrigo 2.5mg tablets function as an aromatase inhibitor, reducing the body's estrogen production. This lowered estrogen level can inhibit or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

Letrigo 2.5mg Tablet consumption alongside alcohol poses no known adverse reactions.

PregnancyPregnancyUNSAFE

Use of Letrigo 2.5mg tablets is strongly contraindicated during pregnancy. Pregnant women should consult their physician, as research in both animals and pregnant humans indicates substantial risks to fetal development.

Breast feedingBreast feedingUNSAFE

Lactation and Letrigo 2.5mg tablets are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Taking a Letrigo 2.5mg tablet might cause drowsiness, blurred vision, and dizziness, reducing alertness. Refrain from driving if you experience these side effects.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney disease can generally use Letrigo 2.5mg Tablets without dose modification. However, data on its use in end-stage kidney disease is scarce. Physician consultation is advised.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Letrigo 2.5mg tablets. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Letrigo 2.5mg Tablet :

Should you forget a Letrigo 2.5mg Tablet dose, take it immediately if you remember. However, near the time for your next dose, omit the missed dose and resume your usual schedule. Never take a double dose.

Facts to Know About Letrigo 2.5mg Tablet

LabelValue
Chemical Category Diphenylmethane derivative
Developing Habits No.
Type of Treatment Cancer Medications

FAQs on Letrigo 2.5mg Tablet

Letrigo 2.5mg tablets are aromatase inhibitors used to treat breast cancer in postmenopausal women.
Letrigo 2.5mg tablets are anti-estrogen medications. They work by inhibiting the aromatase enzyme, thus lowering estrogen levels. Estrogen fuels the growth of certain breast cancers, known as estrogen-dependent cancers. Decreased estrogen production can therefore hinder cancer growth.
For advanced breast cancer or cancer that has spread, continue Letrigo 2.5mg Tablet until tumor progression. Following tamoxifen or surgery, take Letrigo 2.5mg Tablet for five years or until recurrence, whichever occurs first. Alternatively, a sequential regimen of two years of Letrigo 2.5mg Tablet followed by three years of tamoxifen may be used.
While irbesartan and Letrigo 2.5mg Tablet can be taken together, monitor your blood pressure closely as Letrigo 2.5mg Tablet may raise it. Consult your doctor if blood pressure management becomes difficult.
While rare, Letrigo 2.5mg tablets may cause cataracts. Report blurred vision or eye irritation to your doctor immediately.
Experiencing hot flashes may indicate a common side effect of Letrigo 2.5mg Tablet, linked to reduced estrogen levels. These usually lessen as your body adapts, but for some, they may persist throughout treatment and subside afterward. If bothersome, consult your doctor for management options.
While rare, Letrigo 2.5mg Tablet may cause serious side effects in some individuals. These include stroke, angina, heart attack, blood clots, cataracts, osteoporosis, and severe skin reactions.
Letrigo 2.5mg Tablets can lead to bone thinning (osteoporosis) because they lower estrogen levels. Your doctor might monitor your bone density before, during, and after treatment to check for osteoporosis.
The Ministry of Health and Family Welfare restricts Letrigo 2.5mg Tablets to ovulation induction in women with anovulatory infertility.
Letrigo 2.5mg Tablet
162